Renal effects of aspirin and low dose methotrexate in rheumatoid arthritis.
Authors:
- R Müller-SuurRMR Müller-Suur
Open Access
- 1 August 1993
- journal article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 52 (8) , 613-615
Abstract
OBJECTIVES--The aim of this investigation was to study the glomerular and tubular effects of low doses (15 mg) of methotrexate in patients with rheumatoid arthritis with and without combined treatment with aspirin (2 g single dose). METHODS--Renal function was measured by the plasma clearance of EDTA labelled with chromium-51 (51Cr-EDTA) and mercaptoacetyltriglycine labelled with technetium-99m (99mTc-MAG-3). RESULTS--Clearance of 51Cr-EDTA was reduced from 98 (6) to 87 (5) ml/min (mean (SEM)) for patients receiving methotrexate only and further reduced to 76 (5) ml/min for patients receiving methotrexate and aspirin. This effect was reversible as 51Cr-EDTA increased to 85 (6) ml/min during continued treatment with methotrexate alone. Clearance of 99mTc-MAG-3 also decreased from 366 (18) to 315 (17) ml/min in patients receiving methotrexate alone and further to 295 (17) ml/min during treatment with aspirin and methotrexate. Continued treatment with methotrexate alone resulted in a further decrease in the 99mTc-MAG-3 clearance to 253 (17) ml/min. CONCLUSIONS--The study shows that treatment with low doses of methotrexate particularly when combined with aspirin affects glomerular and tubular function. These effects may be of clinical importance and renal function should therefore be monitored with more sensitive methods than serum creatinine as this may not reflect these changes.Keywords
This publication has 10 references indexed in Scilit:
- Aspirin alters methotrexate disposition in rheumatoid arthritis patientsArthritis & Rheumatism, 1991
- Estimation of technetium 99m mercaptoacetyltriglycine lasma clearance by use of one single plasma sampleEuropean Journal of Nuclear Medicine and Molecular Imaging, 1991
- GLOMERULAR-FILTRATION AND TUBULAR SECRETION OF MAG-3 IN THE RAT-KIDNEY1989
- Severe renal toxicity due to intermediate-dose methotrexateCancer Chemotherapy and Pharmacology, 1989
- Technetium-99m labeled renal function and imaging agents: II. Clinical evaluation of 99mTc MAG3 (99mTc mercaptoacetylglycylglycylglycine)International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1988
- Renal Insufficiency in Patients Treated with High Dose MethotrexateActa Oncologica, 1988
- Additive renal effects of indomethacin and dipyridamole in man.British Journal of Clinical Pharmacology, 1987
- SALICYLATE TOXICITY IN ELDERLY PATIENTS WITH RHEUMATOID-ARTHRITIS1987
- Acute renal failure and death following sequential intermediate-dose methotrexate and 5-FU: a possible adverse effect due to concomitant indomethacin administration.1985
- A Simple Method for the Determination of Glomerular Filtration RateScandinavian Journal of Clinical and Laboratory Investigation, 1972